What matters most to patients with multiple myeloma? A Pan-European patient preference study.

MLA

Janssens, Rosanne, et al. “What Matters Most to Patients with Multiple Myeloma? A Pan-European Patient Preference Study.” Frontiers in Oncology, vol. 12, Nov. 2022, p. 1027353. EBSCOhost, https://doi.org/10.3389/fonc.2022.1027353.

APA

Janssens, R., Lang, T., Vallejo, A., Galinsky, J., Morgan, K., Plate, A., De Ronne, C., Verschueren, M., Schoefs, E., Vanhellemont, A., Delforge, M., Schjesvold, F., Cabezudo, E., Vandebroek, M., Stevens, H., Simoens, S., & Huys, I. (2022). What matters most to patients with multiple myeloma? A Pan-European patient preference study. Frontiers in Oncology, 12, 1027353. https://doi.org/10.3389/fonc.2022.1027353

Chicago

Janssens, Rosanne, Tamika Lang, Ana Vallejo, Jayne Galinsky, Kate Morgan, Ananda Plate, Chris De Ronne, et al. 2022. “What Matters Most to Patients with Multiple Myeloma? A Pan-European Patient Preference Study.” Frontiers in Oncology 12 (November): 1027353. doi:10.3389/fonc.2022.1027353.